Smoothened (Smo), a GPCR family protein, plays a critical role in the reception and transduction of Hedgehog (Hh) signal. Smo is phosphorylated and activated on the cell surface; however, it is unknown whether Smo can be intracellularly activated. Here, we demonstrate that inactivation of the ESCRT-III causes dramatic accumulation of Smo in the ESCRT-III/MVB compartment, and subsequent activation of Hh signaling. In contrast, inactivation of ESCRTs 0-II induces mild Smo accumulation in the ESCRT-III/MVB compartment. We provide evidence that Kurtz (Krz), the Drosophila β-arrestin2, acts in parallel with the ESCRTs 0-II pathway to sort Smo to the multivesicular bodies and lysosome-mediated degradation. Additionally, upon inactivation of ESCRT-III, all active and inactive forms of Smo are accumulated. Endogenous Smo accumulated upon ESCRT-III inactivation is highly activated, which is induced by phosphorylation but not sumoylation. Taken together, our findings demonstrate a model for intracellular activation of Smo, raising the possibility for tissue overgrowth caused by an excessive amount, rather than mutation of Smo.
INTRODUCTION
Hedgehog (Hh) signaling controls organ development, tissue homeostasis and body patterning. Malfunction of Hh signaling causes birth defects as well as several types of cancer (Briscoe and Thérond, 2013; Jiang and Hui, 2008) . In Drosophila, the Hh signal is transduced at the plasma membrane, where the receptor complex Patched-Interference Hh (Ptc-Ihog) and the signal transducer Smoothened (Smo) are located. Hh binding to Ptc-Ihog relieves Ptc-mediated inhibition of Smo, which results in Smo activation and then the activation of the Cubitus interruptus (Ci)/Gli family of zinc finger transcription factors, and ultimately induces the expression of Hh target genes, such as decapentaplegic (dpp), ptc, collier (col) and engrailed (en) (Hooper and Scott, 2005; Jia and Jiang, 2006 (Pak and Segal, 2016) .
Studies have shown that Hh induces cell surface accumulation and phosphorylation of Smo by protein kinase A (PKA), casein kinase 1 (CK1), casein kinase 2 (CK2), and G protein-coupled receptor kinase 2 (Gprk2) (Chen and Jiang, 2013; Jiang and Jia, 2015) , as well as atypical PKC (aPKC) (Jiang et al., 2014) . Differential phosphorylation and gradual conformational change in Smo mediates the transduction of Hh activity gradient Zhao et al., 2007) . The cell surface accumulation of Smo is also regulated by endocytosis; ubiquitylation promotes Smo endocytosis and de-ubiquitylation by Ubiquitin-specific protease 8 (USP8) inhibits Smo endocytosis, which ultimately promotes its cell surface accumulation (Li et al., 2012; Xia et al., 2012) . Membrane accumulation and activation of Smo is further regulated by small ubiquitin-like modifier (SUMO) through sumoylation (Ma et al., 2016; Zhang et al., 2017) . These findings indicate that cell surface accumulation promotes the activation of Smo; however, it is unknown whether and how Smo can be activated intracellularly.
Many GPCRs use the intracellular route to activate downstream genes. Studies on GPCRs have demonstrated that activation of receptors, and consequent activation of downstream components, often stimulate the receptor endocytosis (Irannejad and von Zastrow, 2014; Sorkin and von Zastrow, 2009 ). This process may function as a feedback regulation to prevent excessive ligand-induced activation of downstream effectors (Sorkin and von Zastrow, 2009 ). In addition, GPCR phosphorylation and their association with βarrestins play a major role in this process (Irannejad and von Zastrow, 2014) . Molecular sorting machineries determine their ultimate trafficking fate, as receptors either recycle back to the cell surface or are targeted for lysosomal degradation. Unlike other GPCRs, Smo is activated and accumulated on the cell surface upon Hh stimulation. It is unknown whether Smo undergoes intracellular signaling along the endocytic pathway.
The endosomal sorting complex required for transport (ESCRT) machinery includes four ESCRT complexes (ESCRT-0, -I, -II, -III) and Vacuolar protein sorting 4 (Vps4), and these machineries mediate the selection and transport of proteins destined for lysosomal degradation (Hurley and Hanson, 2010; Wollert and Hurley, 2010) . ESCRT facilitates ubiquitylated protein trafficking from endosomes to lysosomes via multivesicular bodies (MVBs) (Henne et al., 2011; Raiborg and Stenmark, 2009; Williams and Urbé, 2007) . Clathrin-dependent endocytosis mediates the activation of epidermal growth factor receptor (EGFR), which is further sorted to the MVB then is trafficked to the lysosome (Goh et al., 2010) . The ESCRTs 0-III protein complexes drive MVB cargo selection; however, ESCRT-III does not directly interact with ubiquitin. Many membrane-bound proteins are actively sorted to different places in the cell from the early endosome (Hurley and Hanson, 2010) . In Drosophila Smo trafficking, the homologs of the ESCRT members mediate sorting of ubiquitylated Smo to endosomes. Smo accumulation is observed upon the inactivation of the ESCRT proteins, such as the Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), a protein that acts within ESCRT-0 (Fan et al., 2013; Li et al., 2012) , Tumor susceptibility gene 101 (Tsg101) in ESCRT-I (Fan et al., 2013; Li et al., 2012) , and Vps36 in ESCRT-II (Yang et al., 2013) . However, inactivation of the proteins of the early endosome, late endosome, or the ESCRTs 0-II causes a mild accumulation of Smo, which is thought to contribute to the cell membrane accumulation and activation of Smo. It is unknown whether Smo can be activated in the intracellular compartments, similar to the activation of many other GPCRs.
In this study, we found that inactivation of the ESCRT-III core subunits, Vps32 (also known as Shrub in Drosophila, Snf7 in yeast, and CHMP4 in mammal) and Vps20 (CHMP6 in mammals), caused a dramatic increase in Smo. Surprisingly, inactivation of either Vps32 or Vps20 induced ectopic Hh target gene expression at higher levels compared to that induced by the inactivation of proteins in the ESCRTs 0-II. Furthermore, we found that 
RESULTS

Inactivation of ESCRT-III results in a high level of Smo and activates Hh target gene expression
Previous studies have shown that Smo undergoes lysosomal degradation that is triggered by ubiquitin-mediated endocytosis (Fan et al., 2013; Li et al., 2012; Xia et al., 2012) . However, it has been puzzling that, in cultured S2 cells, the majority of Smo is present in large puncta that do not colocalize with ubiquitin ( Fig. S1A ). In Drosophila wing discs, the developing wing, posterior (P) compartment cells express and secrete Hh that activates adjacent anterior (A) compartment target gene expression, which is mediated by the Ci transcription factor. The low level of Smo in A-compartment cells away from the A/P boundary indicates a rapid protein degradation ( Fig. 1A) . In wing discs treated with bafilomycin A1 (BFA1) to selectively inhibit vacuolar ATPases that mediate the delivery of internalized proteins from MVB to lysosome, Smo was present in puncta in A-and P-compartment cells (Fig. S1C , compare to Fig. S1B ), suggesting that Smo is indeed trafficked from the MVB to the lysosome for degradation. It is possible that the large puncta of Smo observed in S2 cells are located in larger intracellular compartments, such as the MVB.
To better understand the intracellular trafficking of Smo, we collected RNAi lines from different sources to target ESCRT protein expression. We found that knockdown of Vps32 by RNAi resulted in a high level of accumulation of Smo and Ci (Fig. S2A ). The level of Ptc protein was also increased in A-compartment cells, indicating activation of the Hh pathway ( Fig. S2B ). To more precisely examine the accumulation of Smo in wing discs, we used either P35, a cell death inhibitor, or the inducible Gal80 ts system to prevent cell death induced by Vps32 RNAi. We found that Smo showed high levels of accumulation under both conditions ( Fig. 1B , C, gray panel). We also found that the Smo accumulation caused by Vps32 RNAi in large part did not colocalize with Hrs (marks the ESCRT-0 complex) or Rab7 (marks the late endosome) ( Fig. 1D ; Fig. S2C ), but mostly colocalized with lysosome-associated membrane protein 1 (LAMP1) ( Fig. 1E) , which labels the MVB and lysosome (Pulipparacharuvil et al., 2005; Williams and Urbé, 2007) . The expression of LAMP1-GFP alone did not cause any phenotype in vivo (Pulipparacharuvil et al., 2005) , and did not change Smo accumulation (Fig. S2D ). GFP-tagged Vps32 (Vps32-GFP) has shown to be a dominant negative (Sweeney et al., 2006) . We found that Vps32-GFP colocalized with Smo, and induced Smo and Ci accumulation in the wing disc, likely by blocking the function of endogenous Vps32 (Fig. S2E,F) . These data suggest that the inactivation of Vps32 causes a dramatic accumulation of Smo, which is likely localized in the MVB.
To examine whether the inactivation of Vps32 regulates the activity of Smo, we first used a sensitized genetic background by expressing the partial dominant-negative Smo DN that we previously described as Smo −PKA12 . In this protein, two PKA phosphorylation sites are mutated to avoid phosphorylation (Jia et al., 2004) . Expressing Smo DN through the wing-specific C765-Gal4, a weaker Gal4 line than MS1096-Gal4, resulted in a reproducible phenotype of partial fusion between vein 3 and vein 4, indicative of partial loss of Hh signaling activity ( Fig. S2H , compare to WT wing in Fig. S2G ). We found that Vps32 RNAi reversed the activity of Smo DN , resulting in a rescue of the vein 3-vein 4 fusion phenotype (Fig. S2I ). In comparison, Vps32 RNAi driven by C765-Gal4 produced a mild phenotype in the adult wing ( Fig. S2J ). These data indicate that inactivation of Vps32 regulates the activity of Smo. We further examined Smo accumulation in Vps32 mutant cells and found that Smo showed a dramatic accumulation in Vps32 mutant cells ( Fig. 1F) . Surprisingly, mutating Vps32 induced expression of En, a marker for the peak activation of Hh signaling ( Fig. 1G ). We next investigated cultured S2 cells and found that the levels of Smo were increased upon both Vps32 RNAi and Hh treatment, and that the accumulation of Smo reached a peak level when Vps32 RNAi and Hh treatment were combined ( Fig. 1H ). Consistent with this, Vps32 RNAi significantly increased the ptc-luciferase ( ptc-luc) reporter activity, which was further increased upon Hh treatment ( Fig. 1I ). In these experiments, very high RNAi efficiency was achieved and monitored by quantitative real-time PCR (qRT-PCR) ( Fig. 1J ). In a cell-based assay to examine Smo cell surface accumulation, Hh treatment consistently increased the accumulation of Smo on the cell surface (Jia et al., 2004) (Fig. 1K) ; however, the inactivation of Vps32 significantly increased Smo accumulation inside the cell but not on the cell surface ( Fig. 1K ). These data suggest that Smo can be intracellularly activated during a malfunction of ESCRT-III.
To further examine the ESCRT-III-mediated regulation of Smo accumulation and activation, we used a mutant of Vps20, which is another critical protein in the ESCRT-III complex. We found a high accumulation of Smo in cells with mutated Vps20 ( Fig. 2A) . Consistent with the finding that mutating Vps32 induced Hh target gene expression ( Fig. 1G ), mutation of Vps20 induced ectopic expression of dpp-lacZ and ptc-lacZ, indicating that Smo activates Hh target gene expression in cell autonomous manner ( Fig. 2B ,C; Fig. S3 for higher magnification images). In cultured cells, we found that knockdown of Vps20 by RNAi significantly increased the ptc-luc activity (Fig. 1I) ; however, it did not increase the amount of cell surface-localized Smo (Fig. 1K ). These data confirmed the activation of Smo upon ESCRT-III loss of function. These findings were very interesting because inactivation of the ESCRT-0, ESCRT-I and ESCRT-II increases the cell surface accumulation of Smo but does not significantly increase Hh target gene expression Fan et al., 2013; Li et al., 2012; Yang et al., 2013) , and we therefore did not expect Smo to be activated in the intracellular compartment.
Smo is phosphorylated and activated in ESCRT-IIIcontaining compartments
To determine the active/inactive status of Smo in the intracellular compartment, we first examined the ability of Ptc to inhibit Smo activation. We found that overexpression of Ptc inhibited Smo accumulation and decreased the level of Ci in wild-type cells of the wing disc but not in Vps20-depleted cells (Fig. 2D ). We also examined the levels of endogenous Ptc protein and found that Ptc accumulated upon Vps20 mutation ( Fig. 2E) ; however, the accumulated Ptc, similar to exogenously expressed Ptc protein, did not inhibit Smo ( Fig. 2A) . These data suggest that the accumulation of Smo in the ESCRT-III-containing/MVB compartment is not inhibited by Ptc. To further examine the localization of Smo, we immunostained the wing disc for Vps4 that labels protein localization close to the ESCRT-III/MVB (Rodahl et al., 2009) . We found that Smo colocalized with Vps4 in cells mutating Vps20 ( Recent studies have demonstrated that Smo is activated by sumoylation that is induced by Hh (Ma et al., 2016; Zhang et al., 2017) . We therefore wondered whether the intracellularly accumulated Smo was sumoylated. Using the cell-based assay, we found that, in contrast to Hh treatment, inactivation of Vps32 by RNAi did not change the status of Smo sumoylation ( Fig. 3G ), suggesting that the inactivation of Vps32 increases the levels of Yang et al., 2013) ], were all increased upon Vps32 RNAi (Fig. 4B ). These data suggest that ESCRT-III regulates different forms of Smo. We therefore performed a more precise analysis to examine the stability of the Smo protein at different time points after the treatment by using the protein synthesis inhibitor cycloheximide (CHX). We found that the half-lives of Smo WT and Smo SD123 were increased upon Vps32 RNAi (Fig. 4C,D, middle panel) , compared to the half-lives of these forms of Smo in cells without Vps32 knockdown (Fig. 4C,D, left  panel) , which was further demonstrated by quantification analyses (Fig. 4C,D, right panel) . These data suggest that the active form of
Smo is sorted through ESCRT-III for lysosome-mediated degradation.
It has been shown that ubiquitylation at lysine residues of Smo Ctail promotes, whereas mutating these residues blocks, Smo endocytosis (Li et al., 2012; Xia et al., 2012; Yang et al., 2013) . Interestingly, we found that Smo K42R , with all 42 lysine residues in the Smo C-tail mutated to arginine to block Smo ubiquitylation, accumulated in vps20 mutant cells (Fig. 5B) , which was similar to the observed accumulation of Smo WT in these cells (Fig. 5A ). Both Smo WT and Smo K42R were stabilized by the treatment of BFA1 in cultured S2 cells (data not shown). These data suggest that Smo K42R is sorted into the ESCRT-III-containing/MVB compartment through a different route rather than through the endocytosis pathway. In support of this hypothesis, the half-life of Smo K42R was increased by knockdown of Vps32 in the cell-based assay that focused on Smo stability (Fig. 4E) . To examine the in vivo activity of Smo K42R , we used the tubulin-α promoter, which gives an expression level that is similar to the endogenous Smo expression level (Jia et al., 2010) , and found that Smo K42R rescued ptc and en expression in smo mutant cells (Fig. 5E,F, (Zhu et al., 2003) . To further assess the role of the intracellularly localized Smo in transducing an Hh signal, we generated Smo KKDE , with a fused KKDE motif at the C-terminus, under the control of the tubulin-α promoter. We found that Smo KKDE was able to rescue both Ptc and En expression in smo mutant cells (Fig. 5G,H) . The FDNPVY internalization signal from the LDL receptor is a motif known to promote protein endocytosis (Wang and Struhl, 2004) . We fused a 23-amino-acid peptide that contains the FDNPVY signal to the C-terminus of Smo (Smo FD ). We found that, driven by the tubulin-α promoter, Smo FD fully rescued both Ptc and En expression ( Fig. S4A,B ). Compared to Smo WT , both Smo KKDE and Smo FD showed a significant reduction in cell surface accumulation even when there was Hh stimulation (Fig. S4C) . These data suggest that forcing Smo to localize to the intracellular compartment does not alter its ability to induce Hh target gene expression, demonstrating the signaling activity of intracellularly localized Smo.
Krz acts in parallel to the endocytosis pathway to sort Smo to ESCRT-III
Hrs and Signal transducing adaptor molecule (Stam) constitute the ESCRT-0 complex responsible for the initial selection of ubiquitylated proteins that are ultimately degraded in lysosomes (Henne et al., 2011) . We found that RNAi-mediated knockdown of Hrs caused a mild increase in Smo accumulation (Fig. 6C , compared to 6A), which is consistent with previous findings (Fan et al., 2013; Li et al., 2012) . We also found a mild accumulation of Smo in hrs mutant cells (Fig. S6A) , and that the double mutation of hrs and stam did not increase the accumulation of Smo (Fig. S6B) (Li et al., 2012; Molnar et al., 2011) . Overexpression of Krz prevented Smo accumulation in wing discs but krz mutation did not (Fig. 6E) (Li et al., 2012; Zhang et al., 2017) . Similarly, we found that knockdown of Krz by RNAi did not result in any change in Smo accumulation (Fig. 6B, compared to 6A ). However, Smo accumulation was markedly increased when Krz RNAi and Hrs RNAi were combined (Fig. 6D, compared to 6B and 6C ). In addition, knockdown of Hrs by RNAi in krz mutant cells resulted in the accumulation of Smo to a higher level thatn in krz wild-type cells (Fig. 6F ). It has been shown that Vps32 acts as a key modulator in ligand-independent Notch signaling mediated by Krz and ESCRT-III (Hori et al., 2011) . Our findings led to the hypothesis that Krz and Hrs act in parallel pathways to regulate Smo trafficking. To further test this hypothesis, we examined the ability of Krz to inhibit Smo accumulation under a variety of conditions. We found that, consistent with previous findings, Krz overexpression completely blocked Smo accumulation (Fig. 6G ). Hrs RNAi caused Smo accumulation in both Krzexpressing cells (Fig. 6H ) and wild-type cells (Fig. 6H,I) . Furthermore, overexpression of Krz inhibited Smo accumulation in wild-type cells but not in hrs mutant cells (Fig. 6K) . These results indicate that Hrs and Krz act in parallel to regulate Smo.
To determine how ESCRT-I regulates Smo, we examined the effect of Vps28 loss of function in the ESCRT-I complex. We found that mutating vps28 induced a moderate accumulation of Smo, similar to that caused by hrs mutation (Fig. S6C and A, respectively) . The accumulation of Smo in vps28 mutant cells was not adequate to induce Ci accumulation in the wing disc (Fig. S6C) . These data indicate that the same forms of Smo are trafficked from ESCRT-0-to ESCRT-I-containing compartments. Our finding that both RNAi and mutation of Vps32 caused a striking accumulation of Smo in the ESCRT-III-containing compartment (Figs 1 and 2) suggests that Smo may sort to the ESCRT-III through an ESCRT-0-independent pathway. In support of this hypothesis, we found that Krz overexpression did not inhibit the Smo accumulation that was induced by Vps32 RNAi (Fig. 6J) . The Vps4 complex acts downstream of ESCRT-III to mediate protein degradation through lysosomes. Similar to what was seen with Vps32 RNAi (Fig. 3A;  Fig. S2A ), Smo accumulation was observed when a dominantnegative Vps4 DN was expressed in wing disc (Fig. S6D) . Taken together, our data suggest that the parallel pathways mediated by Krz and Hrs may merge at ESCRT-III to direct additional trafficking and lysosomal degradation.
Autophagy is an evolutionarily conserved, highly regulated cellular process. Autophagosomes can potentially fuse with lysosomes, or with early and late endosomes; however, Vps34 and Beclin 1 play selective roles in the autophagy pathway (Funderburk et al., 2010; Raiborg and Stenmark, 2009 ). To examine whether Smo is regulated by the autophagy, we examined the accumulation of Smo in both wing disc and cultured S2 cells when autophagy gene expression was knocked down by RNAi. We found that knockdown of either Vps34 or Beclin 1 by RNAi did not cause any changes in Smo accumulation or ptc-lacZ expression in wing disc, although both Vps34 and Beclin 1 RNAi induced phenotypes in the adult wing (Fig. S5A,B , data not shown). Consistent with this, inactivation of other autophagy genes, such as Vps15, Atg8a, Atg8b and Atg7, did not cause any changes in Smo accumulation and Hh target gene expression (data not shown). The phenotypes are unlikely to be due to off-target effects because different lines targeting nonoverlapping regions produced similar phenotypes. We also used the cell-based assay to examine Smo stability in S2 cells and found that RNAi for Vps15, Beclin1 and Vps34 did not cause any changes in the levels of Smo (Fig. S5C) . Taken together, we conclude that the autophagy pathway is not involved in Smo stability control.
There is a possibility for Krz to mediate Smo degradation through the proteasome (Li et al., 2012) . The dilemma was to be able to distinguish Krz-mediated Smo sorting to the MVB from that to the proteasome. We explored the possibility of an interaction of Krz with different forms of Smo that are representative of different compartments. We found that endogenous Krz strongly interacted with transfected Myc-Smo WT , indicating that Krz and Smo were physically associated (Fig. 7A, lane 1, top panel) . We further found that Krz interacted with Smo K42R at a level comparable to Smo WT , indicating that mutating the 42 lysine residues in the Smo C-tail did not change the overall association of Krz with Smo (Fig. 7A, lane 2 (Fig. 7A, lanes 3,4, We found that the endogenous Krz protein was very stable and that its stability was not altered by Vps32 RNAi, MG132 (a potent proteasome inhibitor), BFA1 or Hh treatment, suggesting that the endogenous Krz does not undergo degradation through either the proteasome-or lysosome-mediated pathways (Fig. 7B ). We also found that the endogenous Krz protein was stable and was expressed in the wing imaginal disc, with a slightly higher level in the wing pouch, but that no difference was observed between the Acompartment and P-compartment cells (Fig. 7C ), suggesting that the expression or stability of Krz is not regulated by Hh. These data indicate that endogenous Krz is likely recycled before targeting Smo into the proteasome or lysosome, similar to what occurs for ubiquitin recycling in the endocytic pathway. The overexpressed Krz was also very stable and completely blocked Smo accumulation in P-compartment and A-compartment cells near the A/P boundary (Fig. 6G) ; however, Krz overexpression did not alter the expression levels of Ci, Ptc and En (Fig. 7D,E) . These data indicate that the Smo internalized by Krz was active. This was further supported by the finding that overexpression of Krz did not block the accumulation of Cos2 and Fu, but rather increased the levels of Cos2 and Fu in P-compartment cells (Fig. S7A,B) 
DISCUSSION
The regulation of Smo activation has been widely studied, and mainly focused on the identification and characterization of Smo mutations, including those mutations shown in earlier studies to drive cancer formation (Taipale et al., 2000; Xie et al., 1998) parallel with the ESCRTs 0-II pathway to promote Smo degradation through the MVB and lysosome. The Smo that accumulated upon the inactivation of ESCRT-III was highly active, which was likely induced by phosphorylation but not sumoylation. We propose a model for Smo intracellular trafficking regulated by different pathways (Fig. 7F,G) . The findings in this study uncovered a novel mechanism for Smo activation in the intracellular compartment, raising the possibility for tissue over-proliferation caused by an excessive level of Smo induced by the malfunction of ESCRT-III.
The signaling of many GPCRs is controlled by endocytosis. There are incidents of endocytic regulation at the plasma membrane, regulation of signaling by different endocytic routes and signaling from endosomes (Sigismund et al., 2012) . Models have been proposed for GPCR signaling in the endosomes. These include the sustained GPCR signaling from endosomes as is likely to occur for the thyroid-stimulating hormone GPCR (TSHR), and the acute GPCR signaling from endosomes for the D1 dopamine receptor (DRD1) (Irannejad and von Zastrow, 2014 In this study, we show that Krz mediates the internalization of Smo through a pathway parallel to the endosome/ESCRT-0mediated endocytosis. However, there is no effect of krz loss-offunction on Smo accumulation and Hh signaling activity ( Fig. 6E ) (Li et al., 2012; Molnar et al., 2011) . This has been puzzling for years. We provide the following explanations. It is possible that other arrestins compensate for the function of krz when krz is lost. It is also possible that Krz functions in parallel to the endocytosis pathway, allowing Smo to be degraded through other pathways when krz is lost. This latter idea is supported by findings in this study, and also supported by the finding that Krz acts in an ubiquitylation-independent manner to guide Smo to both proteasome-and lysosome-mediated degradation (Li et al., 2012) . (Fig. 7D,E) .
MVB sorting is normally mediated by the ESCRT pathway, in which the MVB cargo selection is determined by the ESCRT 0-III protein complexes (Henne et al., 2011; Hurley and Hanson, 2010) . ESCRTs 0-II contain ubiquitin-binding proteins and are responsible for the sequestration of ubiquitylated proteins. Hrs, containing a ubiquitin-interacting motif (UIM), forms a heterodimer with Stam to constitute ESCRT-0 complex. ESCRT-I contains Vps23, also known as tumor susceptibility gene 101 (Tsg101), which possesses a ubiquitin E2 variant (UEV) domain responsible for cargo recognition. ESCRT-II contains Vps36, which carries a GRAM-like ubiquitin-binding motif in EAP45 (GLUE) domain also responsible for cargo recognition. ESCRT-III, which does not bind ubiquitin directly, contains Vps32 and Vps20, assembles on endosomes and further connects with Vps4 for subsequent entrapment of GPCRs within the MVB. The ESCRT-III complex is pivotal to cargo capture into MVB (Wollert and Hurley, 2010) . The ESCRT/MVB pathway is involved in the trafficking many proteins, and a recent study has found that ESCRT-III and Krz are involved in ligand-independent Notch signaling (Hori et al., 2011) . From the view of Smo trafficking, ubiquitylated Smo can be recognized by ESCRT-0, -I, and -II, and can be clustered into the ESCRT-III-containing compartment after deubiquitylation. ESCRT-III does not bind ubiquitin, raising the possibility that Krz-mediated non-ubiquitylated forms of Smo can be sorted to the ESCRT-III-containing compartment with subsequent lysosomal degradation. We speculate that Smo is activated in the MVB independently of ubiquitylation and sumoylation regulation. In support this concept, we found that the accumulation of Smo upon inactivation of the ESCRT-III did not alter the ubiquitylation and sumoylation of Smo (Fig. 3F,G) . The other supportive finding was that the active forms of Smo underwent lysosome-mediated degradation (Fig. 4D ). Many lysine residues in the Smo C-tail can be either sumoylated or ubiquitylated (Li et al., 2012; Ma et al., 2016; Xia et al., 2012; Yang et al., 2013; Zhang et al., 2017) (Fig. 3D,E) , which likely induces dimerization and activation of the protein.
It is interesting that the overexpressed Krz blocked Smo accumulation, but increased Fu and Cos2 accumulation in Pcompartment cells (Fig. S7A,B ). This indicates that the components were not accumulated in cells with mutated vps20 (Fig. S7C,D) , suggesting that the accumulation and activation of Smo does not promote the accumulation of Fu and Cos2 in these cells. These data also suggest that Krz likely acts upstream of ESCRT-III to regulate Smo trafficking. Taken together with the finding that the intracellular activation of Smo does not require sumoylation, we speculate that the activation of Smo in the intracellular compartment is mediated in a different way from its activation on the cell surface.
MATERIALS AND METHODS
Constructs, mutants and transgenes
Generation of the Myc-Smo WT , Myc-Smo SD123 , Myc-Smo PKA123 and
Smo-CFP constructs was previously described (Jia et al., 2004; Liu et al., 2007 (Yang et al., 2013) . HA-Ub, HA-SUMO and Flag-Ubc9 were as previously described (Xia et al., 2012; Zhang et al., 2017 (Xia et al., 2012) . The HA-Krz construct and transgenic line have been described previously (Zhang et al., 2017) . The HA-Ptc construct and transgenic line have been described previously . All the transgenic lines were generated by using the 75B1 VK5-attP locus to ensure Smo protein expression at the same levels without positional effects.
The wing-specific MS1096-Gal4 and wing dorsal-compartment-specific ap-Gal4 have been described in our previous studies (Jia et al., 2010 (Jia et al., , 2003 . vps32 G5 and vps32 O3 were obtained from Bloomington Stock Center (BSC) (#39635 and #39623, respectively), and vps32 mutant clones shown in this study were generated by using the vps32 G5 mutant combined with FRT42D. To generate survival clones, UAS-P35 was expressed in wing disc through MS1096-Gal4. The HA-Krz transgenic insertion on the second chromosome and the krz mutant line have been described previously (Mukherjee et al., 2005) . krz mutant clones were generated by using the krz mutant combined with FRT82B. vps28 mutant clones were generated with the vps28 B9 -FRT42D stock from BSC (#39634). Genotypes for examining the activity of the Smo transgene in smo clones were: yw hsp-flp/+ or Y; smo3 FRT40/hs-GFP FRT40; tub-Smo-variant/+. Gal80 ts flies were from BSC (#7017 and #7108). Vps32 RNAi lines #38305 from BSC and v106823 from the Vienna Drosophila Research Center (VDRC) gave rise to similar phenotypes, thus v106823 was used for most of the experiments. The Hrs RNAi lines from Bloomington (#28026 and #28964) or VDRC (v20933) gave rise to similar phenotypes and were characterized in our previous study (Fan et al., 2013) . The Vps32-GFP line from Dr Fen-Biao Gao (University of Massachusetts) and the Vps32-GFP line from BSC (#32559) consistently showed a dominantnegative effect in wing discs. The transgenic line with Vps4 DN carrying E232Q mutation was a gift from Drs Harald Stenmark and Tor Erik Rusten (Oslo University Hospital) (Rusten et al., 2007) . The LAMP1-GFP line was a gift from Dr Helmut Kramer (UT Southwestern). The Krz RNAi line v41559 was from the VDRC and RNAi efficiency in wing disc was confirmed by use of anti-Krz antibody (1:50, PA1-730, Thermo Scientific) upon immunostaining of the wing disc. The Hh RNAi line v1402 was obtained from the VDRC and characterized in our previous studies. Beclin1 (also known as Atg6 and Vps30) RNAi (#28060), Vps34RNAi (#33384 and #64011), Vps15 RNAi (#34092 and #57011), Atg7 RNAi (#27707), Atg8a RNAi (#34340 and #28989) and Atg8b RNAi (#27554) were obtained from the BSC.
according to the manufacturer's instructions. The quantitative real-time PCR reactions were carried out using SYBR Green PCR master mix reagents (Thermo Scientific) on the ABI StepOnePlus real-time PCR system (Applied Biosystems). Thermal cycling was conducted at 95°C for 30 s, followed by 40 cycles of amplification at 95°C for 5 s, 55°C for 30 s and 72°C for 15 s. The following primers were used: Vps32, 5′-GACGAACTGAATATAGCCCG-3′ and 5′-TCATGTCGTGCACCTTGTCC-3′; Vps20, 5′-GATGTGCCCA-CCGAAGATCT-3′ and 5′-CAGGACTTTCTTGGTTGCTT-3′.
The cell-based assay to examine Smo cell surface accumulation was carried out by immunostaining with the anti-SmoN antibody before cell permeabilization. After incubation with the anti-SmoN antibody at room temperature for 30 min, cells were washed with PBS and fixed with 4% formaldehyde in PBS for 20 min. After permeabilization with 1% PBST, cells were then incubated with the anti-Myc antibody for 1 h (unless autofluorescence of CFP was to be measured), appropriate secondary antibody for 1 h, washed three times with PBST after each incubation, and finally mounted on slides with 80% glycerol. For maximal Hh signal strength, a UAST-Hh construct was also included in the transfection . Fluorescence signals were acquired with the 60× objective on an Olympus confocal microscope. Smo density was analyzed with ImageJ software (NIH, version 1.48v).
For the ptc-luc reporter assay, S2 cells were cultured in six-well plates and transfected with 50 ng tub-Ci, 20 ng renilla and 150 ng ptc-luc reporter vectors. At 48 h post-transfection, cells were lysed for luciferase activity analysis with the dual-luciferase reporter assay system (Promega, Madison, WI). Renilla luciferase was used to normalize the luciferase activity. The measurements of dual-luciferase were determined with a GLOMAX Multi Detection System (Promega).
Presented data are representative of three experiments, with standard deviation (s.d.) bars generated from four replicates. For statistical analysis, Student's t-test was used for cell culture studies involving two independent groups.
Antibodies used in this study for western blotting were: mouse anti-Myc (1:5000; 9E10, Santa Cruz Biotechnology), anti-HA (1:1000; F7, Santa Cruz Biotechnology, anti-GFP (1:500; MAB3580, Millipore), rabbit anti-Myc (1:2000; A-14, Santa Cruz Biotechnology), anti-SmoP (1:50; , and anti-Krz (1:2500; PA1-730, Thermo Scientific).
